Biogen Cuts FY Adjusted View as Profit Declines
Biogen’s second-quarter profit plummeted and the biopharmaceutical company cut its full-year adjusted earnings forecast.
Biogen’s second-quarter profit plummeted and the biopharmaceutical company cut its full-year adjusted earnings forecast.